propranolol has been researched along with Retinal Diseases in 5 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Retinal Diseases: Diseases involving the RETINA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol was initiated with a progressive increase up to a final dose of 120 mg daily." | 5.46 | Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. ( Albiñana, V; Botella, LM; Escribano, RMJ; Padial, LR; Recio-Poveda, L; Soler, I; Villar Gómez de Las Heras, K, 2017) |
| "The serendipitous demonstration that the nonselective β-adrenergic receptor (β-AR) antagonist propranolol promotes the regression of infantile hemangiomas (IHs) aroused interest around the involvement of the β-adrenergic system in angiogenic processes." | 4.91 | Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system. ( Bagnoli, P; Casini, G; Dal Monte, M; Daniotti, M; Filippi, L; Sereni, F, 2015) |
| "Propranolol was initiated with a progressive increase up to a final dose of 120 mg daily." | 1.46 | Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. ( Albiñana, V; Botella, LM; Escribano, RMJ; Padial, LR; Recio-Poveda, L; Soler, I; Villar Gómez de Las Heras, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albiñana, V | 1 |
| Escribano, RMJ | 1 |
| Soler, I | 1 |
| Padial, LR | 1 |
| Recio-Poveda, L | 1 |
| Villar Gómez de Las Heras, K | 1 |
| Botella, LM | 1 |
| Filippi, L | 1 |
| Dal Monte, M | 1 |
| Casini, G | 1 |
| Daniotti, M | 1 |
| Sereni, F | 1 |
| Bagnoli, P | 1 |
| Tatham, A | 1 |
| Macfarlane, A | 1 |
| Raper, AJ | 1 |
| Jessee, EF | 1 |
| Texter, JH | 1 |
| Giffler, RF | 1 |
| Hietala, TS | 1 |
| Katz, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC)[NCT02354170] | Phase 2 | 16 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for propranolol and Retinal Diseases
| Article | Year |
|---|---|
Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
Topics: Adrenergic beta-Antagonists; Animals; Cell Line, Tumor; Child, Preschool; Hemangioma; Humans; Hypoxi | 2015 |
4 other studies available for propranolol and Retinal Diseases
| Article | Year |
|---|---|
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
Topics: Adolescent; Adult; Biomarkers; Female; Hemangioblastoma; Humans; Male; MicroRNAs; Middle Aged; Propr | 2017 |
The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Choroid Diseases; Female; Humans; Proprano | 2006 |
Pheochromocytoma of the urinary bladder: a broad clinical spectrum.
Topics: Adult; Catecholamines; Female; Humans; Hypertension; Phenoxybenzamine; Phentolamine; Pheochromocytom | 1977 |
Migrainous central retinal artery occlusion.
Topics: Adult; Arterial Occlusive Diseases; Humans; Male; Migraine Disorders; Propranolol; Retinal Artery; R | 1986 |